Design, synthesis and antiplasmodial activity of novel imidazole derivatives based on 7-chloro-4-aminoquinoline. 2018

Srinivasarao Kondaparla, and Ashan Manhas, and Vasantha Rao Dola, and Kumkum Srivastava, and Sunil K Puri, and S B Katti
Medicinal & Process Chemistry Division, CSIR-Central Drug Research Institute Sector-10, Jankipuram Extension, Sitapur Road, Lucknow 226031, India. Electronic address: srinu086@gmail.com.

A series of short chain 4-aminoquinoline-imidazole derivatives have been synthesized in one pot two step multicomponent reaction using van leusen standard protocol. The diethylamine function of chloroquine is replaced by substituted imidazole derivatives containing tertiary terminal nitrogen. All the synthesized compounds were screened against the chloroquine sensitive (3D7) and chloroquine resistant (K1) strains of Plasmodium falciparum. Some of the compounds (6, 8, 9 and 17) in the series exhibited comparable activity to CQ against K1 strain of P. falciparum. All the compounds displayed resistance factor between 0.09 and 4.57 as against 51 for CQ. Further, these analogues were found to form a strong complex with hematin and inhibit the β-hematin formation, therefore these compounds act via heme polymerization target.

UI MeSH Term Description Entries
D007093 Imidazoles Compounds containing 1,3-diazole, a five membered aromatic ring containing two nitrogen atoms separated by one of the carbons. Chemically reduced ones include IMIDAZOLINES and IMIDAZOLIDINES. Distinguish from 1,2-diazole (PYRAZOLES).
D010963 Plasmodium falciparum A species of protozoa that is the causal agent of falciparum malaria (MALARIA, FALCIPARUM). It is most prevalent in the tropics and subtropics. Plasmodium falciparums,falciparums, Plasmodium
D002470 Cell Survival The span of viability of a cell characterized by the capacity to perform certain functions such as metabolism, growth, reproduction, some form of responsiveness, and adaptability. Cell Viability,Cell Viabilities,Survival, Cell,Viabilities, Cell,Viability, Cell
D002522 Chlorocebus aethiops A species of CERCOPITHECUS containing three subspecies: C. tantalus, C. pygerythrus, and C. sabeus. They are found in the forests and savannah of Africa. The African green monkey is the natural host of SIMIAN IMMUNODEFICIENCY VIRUS and is used in AIDS research. African Green Monkey,Cercopithecus aethiops,Cercopithecus griseoviridis,Cercopithecus griseus,Cercopithecus pygerythrus,Cercopithecus sabeus,Cercopithecus tantalus,Chlorocebus cynosuros,Chlorocebus cynosurus,Chlorocebus pygerythrus,Green Monkey,Grivet Monkey,Lasiopyga weidholzi,Malbrouck,Malbrouck Monkey,Monkey, African Green,Monkey, Green,Monkey, Grivet,Monkey, Vervet,Savanah Monkey,Vervet Monkey,Savannah Monkey,African Green Monkey,Chlorocebus cynosuro,Green Monkey, African,Green Monkeys,Grivet Monkeys,Malbrouck Monkeys,Malbroucks,Monkey, Malbrouck,Monkey, Savanah,Monkey, Savannah,Savannah Monkeys,Vervet Monkeys
D004351 Drug Resistance Diminished or failed response of an organism, disease or tissue to the intended effectiveness of a chemical or drug. It should be differentiated from DRUG TOLERANCE which is the progressive diminution of the susceptibility of a human or animal to the effects of a drug, as a result of continued administration. Resistance, Drug
D006427 Hemin Chloro(7,12-diethenyl-3,8,13,17-tetramethyl-21H,23H-porphine-2,18-dipropanoato(4-)-N(21),N(22),N(23),N(24)) ferrate(2-) dihydrogen. Ferriprotoporphyrin,Hematin,Alkaline Hematin D-575,Chlorohemin,Ferrihaem,Ferriheme Chloride,Ferriprotoporphyrin IX,Ferriprotoporphyrin IX Chloride,Panhematin,Protohemin,Protohemin IX,Alkaline Hematin D 575,Chloride, Ferriheme,Chloride, Ferriprotoporphyrin IX,Hematin D-575, Alkaline
D000634 Aminoquinolines Quinolines substituted in any position by one or more amino groups.
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000962 Antimalarials Agents used in the treatment of malaria. They are usually classified on the basis of their action against plasmodia at different stages in their life cycle in the human. (From AMA, Drug Evaluations Annual, 1992, p1585) Anti-Malarial,Antimalarial,Antimalarial Agent,Antimalarial Drug,Anti-Malarials,Antimalarial Agents,Antimalarial Drugs,Agent, Antimalarial,Agents, Antimalarial,Anti Malarial,Anti Malarials,Drug, Antimalarial,Drugs, Antimalarial
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships

Related Publications

Srinivasarao Kondaparla, and Ashan Manhas, and Vasantha Rao Dola, and Kumkum Srivastava, and Sunil K Puri, and S B Katti
October 2012, Bioorganic & medicinal chemistry,
Srinivasarao Kondaparla, and Ashan Manhas, and Vasantha Rao Dola, and Kumkum Srivastava, and Sunil K Puri, and S B Katti
April 2023, ChemMedChem,
Srinivasarao Kondaparla, and Ashan Manhas, and Vasantha Rao Dola, and Kumkum Srivastava, and Sunil K Puri, and S B Katti
October 2012, Bioorganic & medicinal chemistry,
Srinivasarao Kondaparla, and Ashan Manhas, and Vasantha Rao Dola, and Kumkum Srivastava, and Sunil K Puri, and S B Katti
September 2014, Acta pharmaceutica (Zagreb, Croatia),
Srinivasarao Kondaparla, and Ashan Manhas, and Vasantha Rao Dola, and Kumkum Srivastava, and Sunil K Puri, and S B Katti
January 2015, European journal of medicinal chemistry,
Srinivasarao Kondaparla, and Ashan Manhas, and Vasantha Rao Dola, and Kumkum Srivastava, and Sunil K Puri, and S B Katti
May 1969, Journal of medicinal chemistry,
Srinivasarao Kondaparla, and Ashan Manhas, and Vasantha Rao Dola, and Kumkum Srivastava, and Sunil K Puri, and S B Katti
September 2009, Bioorganic & medicinal chemistry,
Srinivasarao Kondaparla, and Ashan Manhas, and Vasantha Rao Dola, and Kumkum Srivastava, and Sunil K Puri, and S B Katti
January 2012, Chemical & pharmaceutical bulletin,
Srinivasarao Kondaparla, and Ashan Manhas, and Vasantha Rao Dola, and Kumkum Srivastava, and Sunil K Puri, and S B Katti
October 2016, European journal of medicinal chemistry,
Srinivasarao Kondaparla, and Ashan Manhas, and Vasantha Rao Dola, and Kumkum Srivastava, and Sunil K Puri, and S B Katti
July 2014, Bioorganic & medicinal chemistry,
Copied contents to your clipboard!